Exchange Traded Concepts LLC Cuts Stake in Addus HomeCare Co. (NASDAQ:ADUS)

Exchange Traded Concepts LLC reduced its stake in shares of Addus HomeCare Co. (NASDAQ:ADUS) by 12.8% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,773 shares of the company’s stock after selling 845 shares during the quarter. Exchange Traded Concepts LLC’s holdings in Addus HomeCare were worth $768,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also added to or reduced their stakes in ADUS. Vanguard Group Inc. boosted its position in shares of Addus HomeCare by 1.5% during the 1st quarter. Vanguard Group Inc. now owns 1,276,467 shares of the company’s stock valued at $131,910,000 after acquiring an additional 19,027 shares during the last quarter. Wellington Management Group LLP boosted its position in shares of Addus HomeCare by 1.2% during the 4th quarter. Wellington Management Group LLP now owns 798,435 shares of the company’s stock valued at $74,135,000 after acquiring an additional 9,548 shares during the last quarter. Point72 Asset Management L.P. boosted its position in shares of Addus HomeCare by 73.4% during the 2nd quarter. Point72 Asset Management L.P. now owns 745,824 shares of the company’s stock valued at $86,598,000 after acquiring an additional 315,602 shares during the last quarter. Dimensional Fund Advisors LP boosted its position in shares of Addus HomeCare by 0.8% during the 2nd quarter. Dimensional Fund Advisors LP now owns 714,253 shares of the company’s stock valued at $82,930,000 after acquiring an additional 5,421 shares during the last quarter. Finally, Principal Financial Group Inc. boosted its position in shares of Addus HomeCare by 20.9% during the 2nd quarter. Principal Financial Group Inc. now owns 430,444 shares of the company’s stock valued at $49,979,000 after acquiring an additional 74,488 shares during the last quarter. 95.35% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other news, EVP Michael D. Wattenbarger sold 21,917 shares of the company’s stock in a transaction on Monday, August 26th. The stock was sold at an average price of $133.29, for a total value of $2,921,316.93. Following the transaction, the executive vice president now owns 7,215 shares of the company’s stock, valued at $961,687.35. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. In other Addus HomeCare news, EVP Michael D. Wattenbarger sold 21,917 shares of the company’s stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the sale, the executive vice president now owns 7,215 shares in the company, valued at $961,687.35. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Esteban Lopez sold 500 shares of the company’s stock in a transaction dated Wednesday, September 4th. The stock was sold at an average price of $130.03, for a total value of $65,015.00. Following the sale, the director now owns 3,866 shares in the company, valued at approximately $502,695.98. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 22,917 shares of company stock valued at $3,050,082 in the last quarter. Insiders own 4.60% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have recently commented on the company. KeyCorp assumed coverage on Addus HomeCare in a research report on Friday, October 11th. They set an “overweight” rating and a $150.00 target price for the company. Stephens reiterated an “overweight” rating and set a $138.00 target price on shares of Addus HomeCare in a research report on Tuesday, August 6th. Royal Bank of Canada restated an “outperform” rating and issued a $141.00 price target on shares of Addus HomeCare in a research report on Tuesday, September 3rd. Macquarie restated an “outperform” rating and issued a $139.00 price target on shares of Addus HomeCare in a research report on Friday, October 11th. Finally, StockNews.com downgraded Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research report on Sunday, July 7th. One research analyst has rated the stock with a sell rating, eight have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, Addus HomeCare currently has a consensus rating of “Moderate Buy” and a consensus price target of $131.38.

Addus HomeCare Stock Performance

NASDAQ ADUS opened at $131.81 on Friday. The stock’s fifty day moving average is $130.48 and its two-hundred day moving average is $118.14. The firm has a market capitalization of $2.39 billion, a P/E ratio of 32.71, a price-to-earnings-growth ratio of 2.33 and a beta of 1.04. Addus HomeCare Co. has a fifty-two week low of $78.35 and a fifty-two week high of $136.12.

Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings data on Monday, August 5th. The company reported $1.35 earnings per share for the quarter, topping analysts’ consensus estimates of $1.21 by $0.14. The company had revenue of $286.90 million for the quarter, compared to analyst estimates of $284.90 million. Addus HomeCare had a return on equity of 9.81% and a net margin of 6.18%. The firm’s revenue for the quarter was up 10.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.94 earnings per share. As a group, sell-side analysts forecast that Addus HomeCare Co. will post 4.58 EPS for the current year.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.